Zak Mir interviews Richard Jennings, CEO, Align Research, discussing the on goings of the past year and the outlook for 2018.

Key points discussed

1. Addressing twitter/bulletin board “trolls”
2. Elaboration on some of the top 10 picks for 2018
3. Global markets outlook
4. Business model background

• Acasti Pharma
• Align Research
• Cradle Arc
• Growth shares
• Management Resource Solutions
• Mayan Energy
• Pathfinder Minerals
• Sentiment
• Value shares